Genome-wide analysis of estrogen receptor binding sites
Nature genetics, 2006•nature.com
The estrogen receptor is the master transcriptional regulator of breast cancer phenotype and
the archetype of a molecular therapeutic target. We mapped all estrogen receptor and RNA
polymerase II binding sites on a genome-wide scale, identifying the authentic cis binding
sites and target genes, in breast cancer cells. Combining this unique resource with gene
expression data demonstrates distinct temporal mechanisms of estrogen-mediated gene
regulation, particularly in the case of estrogen-suppressed genes. Furthermore, this …
the archetype of a molecular therapeutic target. We mapped all estrogen receptor and RNA
polymerase II binding sites on a genome-wide scale, identifying the authentic cis binding
sites and target genes, in breast cancer cells. Combining this unique resource with gene
expression data demonstrates distinct temporal mechanisms of estrogen-mediated gene
regulation, particularly in the case of estrogen-suppressed genes. Furthermore, this …
Abstract
The estrogen receptor is the master transcriptional regulator of breast cancer phenotype and the archetype of a molecular therapeutic target. We mapped all estrogen receptor and RNA polymerase II binding sites on a genome-wide scale, identifying the authentic cis binding sites and target genes, in breast cancer cells. Combining this unique resource with gene expression data demonstrates distinct temporal mechanisms of estrogen-mediated gene regulation, particularly in the case of estrogen-suppressed genes. Furthermore, this resource has allowed the identification of cis-regulatory sites in previously unexplored regions of the genome and the cooperating transcription factors underlying estrogen signaling in breast cancer.
nature.com